Mark S. Schroeder - 05 Nov 2021 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role: EVP, President-Diagnostics Lab
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol: LH
Transactions as of: 05 Nov 2021
Net transactions value: -$247,081
Form type: 4
Filing time: 09 Nov 2021, 13:46:02 UTC
Next filing: 04 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Options Exercise		+2,010	+39%		7,139	05 Nov 2021	Direct	F1, F2
transaction	LH	Common Stock	Tax liability	$247,081	-899	-13%	$274.84	6,240	05 Nov 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Restricted Stock Unit	Options Exercise	$0	-2,010	-30%	$0.000000	4,744	05 Nov 2021	Common Stock	2,010		Direct	F1, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2	Amount includes 123.1200 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3	Stock withholding to satisfy tax withholding obligations.
F4	The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 5, 2020.
F5	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.